Skip to main content
OpenTrials

Clinical trial condition

Neurofibroma

Explore clinical trials studying Neurofibroma. Study availability and eligibility vary by location and protocol.

237 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Neurofibroma trial results

Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

NCT05732831

Conditions
Adenocarcinoma, Adenoma, Carcinoma, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Grand Valley Oncology Grand Junction, Colorado, United States
  • Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 26 locations
View Trial Details
Recruiting

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

NCT05849662

Conditions
Bone Marrow Diseases, CBL Syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital of Colorado Denver, Colorado, United States
View all 21 locations
View Trial Details
Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

NCT04374305

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +38 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Miami Miami, Florida, United States
  • Indiana University School of Medicine Indianopolis, Indiana, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Recruiting

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

NCT02544022

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Recruiting

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

NCT05489783

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Glioma, +15 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia

NCT07088991

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +11 more
Locations
  • Research Site Arkhangelsk, Russia
  • Research Site Chelyabinsk, Russia
  • Research Site Grozny, Russia
  • Research Site Krasnoyarsk, Russia
View all 16 locations
View Trial Details

Related conditions